This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk Healthcare Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Lorna Mitchell and Her Patent on Pyruvate Kinase Activators.
Introduction
Lorna Mitchell is an inventor associated with Cambridge, Massachusetts, and Novo Nordisk Healthcare AG. Her patent work concerns compounds designed to activate pyruvate kinase, an enzyme relevant to cellular metabolism.
Latest Patents
Mitchell is credited with 1 patent: “Pyrrolopyrrole Compositions as Pyruvate Kinase (PKR) Activators.” The disclosure describes novel chemical compounds that modulate and activate PKR, along with potential uses for those compounds. The patent identifies possible applications in conditions associated with PKR and/or PKM2, including pyruvate kinase deficiency, sickle cell disease, and thalassemia.
Career Highlights
Mitchell’s listed patent reflects work at the intersection of medicinal chemistry and therapeutic research. The disclosed compounds are presented as potential tools for addressing diseases and disorders linked to pyruvate kinase activity.
Collaborations
Neal Green is identified as Mitchell’s coworker. The available information does not specify his role in the patent or the nature of their collaboration.
Conclusion
Lorna Mitchell’s patent documents a research contribution focused on pyrrolopyrrole compounds and their potential to activate pyruvate kinase in the study of several serious disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile